Q515--575 Anatomic Pathology Services per Statement of Work New 5 Year Blanket Purchase Agreement

Where this opportunity stands

Every notice posted under solicitation 36C25925Q0293 in this department, oldest first.

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

• Decide bid or no bid before the response deadline.
• Look at the past winners for likely competitors and teaming partners.
• Follow the opportunity to hear about amendments and the award.

What the notice says

Who won similar work

4 award notices on SAM.gov in the last 24 months. Matched by: Same office (NETWORK CONTRACT OFFICE 19 (36C259)), same NAICS 621511.

Single-winner award sizes (4): middle half $595K to $1.0M, median $820K; range $486K to $1.1M.

Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.

• Sep 22, 2026CYTOPATH BIOPSY LAB INC$1.0MQ301-- Molecular Thyroid TestingNo listed company matched (Materiality N/A)
• Sep 16, 2026EXOSOME DIAGNOSTICS INC$1.1MQ301--Base Year | 36C259-26-AP-1918 | Prostate Testing Non-Invasive | VISN ContractMateriality: 0.09% of $TECH revenue (Low)Calculated as Award Amount divided by the company's trailing twelve-month revenue (SEC 10-Q). For this company the latest 10-K year is used. Here: $1.1M award ÷ $1.2B revenue, fiscal year ending Jun 30, 2026 (SEC 10-K). SEC
• May 29, 2026VERACYTE LABS SD CORPORATION$486KQ301--5 Year BPA Decipher Prostate TestMateriality: 0.09% of $VCYT revenue (Low)Calculated as Award Amount divided by the company's trailing twelve-month revenue (SEC 10-Q). Here: $486K award ÷ $561.9M revenue, 12 months to Jun 30, 2026 (SEC 10-Q). SEC
• Feb 27, 2026KASHI CLINICAL LABORATORIES, LLC$632KQ515--Five Year Blanket Purchase Agreement Salt Lake City Heart and Kidney Transplant Rejection Test Services and ReportingNo listed company matched (Materiality N/A)

Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.

Competitive landscape

For the 4 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.